Unknown

Dataset Information

0

Cooperation of the ATM and Fanconi Anemia/BRCA Pathways in Double-Strand Break End Resection.


ABSTRACT: Cells deficient in ataxia telangiectasia mutated (ATM) are hypersensitive to ionizing radiation and other anti-cancer agents that induce double-strand DNA breaks. ATM inhibitors may therefore sensitize cancer cells to these agents. Some cancers may also have underlying genetic defects predisposing them to an ATM inhibitor monotherapy response. We have conducted a genome-wide CRISPR screen to identify genetic vulnerabilities that sensitize lung cancer cells to ATM inhibitors. Knockout of genes in the Fanconi anemia (FA)/BRCA pathway results in hypersensitivity to the ATM inhibitor M3541. Knockdown of either an FA gene or of ATM results in reduced double-strand break end resection, enhanced non-homologous end joining (NHEJ) repair, and decreased homologous recombination repair. Knockout of both the FA/BRCA pathway and ATM strongly inhibits end resection and generates toxic levels of NHEJ, thereby elucidating a mechanism of cellular death by synthetic lethality. ATM inhibitors may therefore be useful for the treatment of tumors with a defective FA/BRCA pathway.

SUBMITTER: Cai MY 

PROVIDER: S-EPMC8713357 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2016-08-06 | GSE85253 | GEO
2016-08-06 | E-GEOD-85253 | biostudies-arrayexpress
| S-EPMC5234563 | biostudies-literature
| S-EPMC11329772 | biostudies-literature
| S-EPMC9098523 | biostudies-literature
| S-EPMC3213282 | biostudies-literature
| S-EPMC7102959 | biostudies-literature
| S-EPMC4079050 | biostudies-literature
| S-EPMC6846210 | biostudies-literature
2020-01-20 | PXD016256 | Pride